Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin: STRUCTURAL AND KINETIC ASPECTS

Schistosomiasis is a parasitic disease affecting over 200 million people currently treated with one drug, praziquantel. A possible drug target is the seleno-protein thioredoxin-glutathione reductase (TGR), a key enzyme in the pathway of the parasite for detoxification of reactive oxygen species. The...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Angelucci, Francesco, Sayed, Ahmed A., Williams, David L., Boumis, Giovanna, Brunori, Maurizio, Dimastrogiovanni, Daniela, Miele, Adriana E., Pauly, Frida, Bellelli, Andrea
Format: Artigo
Idioma:Inglês
Publicat: American Society for Biochemistry and Molecular Biology 2009
Matèries:
Enzyme Catalysis and Regulation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2781444/
https://ncbi.nlm.nih.gov/pubmed/19710012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M109.020701
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars